Catalyst Wire Dossier Catalyst Wire Dossier

Nevirapine XR Formulation 1

nevirapine extended-release · Boeehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nevirapine XR Formulation 1, covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers [Phase 1]

See pricing